Mathematical Modeling of Protein Misfolding Mechanisms in Neurological Diseases: A Historical Overview
暂无分享,去创建一个
Alan C. Evans | Felix Carbonell | Yasser Iturria-Medina | F. Carbonell | Y. Iturria-Medina | Y. Iturria-medina
[1] J. Hofrichter,et al. Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism. , 1985, Journal of molecular biology.
[2] D. Kirschner,et al. Kinetic theory of fibrillogenesis of amyloid beta-protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[3] Toshiki Uchihara,et al. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies , 2015, Acta Neuropathologica.
[4] Andrea Tosin,et al. Alzheimer's disease: a mathematical model for onset and progression. , 2015, Mathematical medicine and biology : a journal of the IMA.
[5] Vincenzo Martorana,et al. Protofibril Formation of Amyloid β-Protein at Low pH via a Non-cooperative Elongation Mechanism* , 2005, Journal of Biological Chemistry.
[6] Tuomas P. J. Knowles,et al. Mean-field master equation formalism for biofilament growth , 2014 .
[7] L. Edelstein-Keshet,et al. Exploring the formation of Alzheimer's disease senile plaques in silico. , 2002, Journal of theoretical biology.
[8] Raimon Sabaté,et al. Evidence of the existence of micelles in the fibrillogenesis of beta-amyloid peptide. , 2005, The journal of physical chemistry. B.
[9] J. Trojanowski,et al. Spreading of pathology in neurodegenerative diseases: a focus on human studies , 2015, Nature Reviews Neuroscience.
[10] F. Ferrone,et al. Analysis of protein aggregation kinetics. , 1999, Methods in enzymology.
[11] H Fraser,et al. Scrapie in the central nervous system: neuroanatomical spread of infection and Sinc control of pathogenesis. , 1992, The Journal of general virology.
[12] R J Fletterick,et al. Structural clues to prion replication. , 1994, Science.
[13] Paul M. Thompson,et al. Localizing Sources of Brain Disease Progression with Network Diffusion Model , 2016, IEEE Journal of Selected Topics in Signal Processing.
[14] Benjamin J. Shannon,et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.
[15] Dietmar Oelz,et al. Size distribution dependence of prion aggregates infectivity. , 2009, Mathematical biosciences.
[16] Peter T. Lansbury,et al. Assembly of Aβ Amyloid Protofibrils: An in Vitro Model for a Possible Early Event in Alzheimer's Disease† , 1999 .
[17] C. Dobson. Protein folding and misfolding , 2003, Nature.
[18] Hansjürgen Bratzke,et al. Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.
[19] Brian Spencer,et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein , 2009, Proceedings of the National Academy of Sciences.
[20] Tuomas P. J. Knowles,et al. On the lag phase in amyloid fibril formation , 2015, Physical chemistry chemical physics : PCCP.
[21] R M Murphy,et al. Probing the kinetics of beta-amyloid self-association. , 2000, Journal of structural biology.
[22] Carole J Proctor,et al. Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer’s disease: a stochastic modelling approach , 2012, Molecular Neurodegeneration.
[23] Laurent Pujo-Menjouet,et al. Analysis of a model for the dynamics of prions , 2005 .
[24] Lawrence M. Wein,et al. The Impact of Novel Treatments on A\03B2 Burden in Alzheimer's Disease: Insights From a Mathematical Model , 2015 .
[25] Glenn F. Webb,et al. Analysis of a model for the dynamics of prions II , 2005 .
[26] V. Calvez,et al. Prion dynamics with size dependency–strain phenomena , 2010, Journal of biological dynamics.
[27] F. Ferrone,et al. Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway. , 1984, Biophysical journal.
[28] Alan C. Evans,et al. Multifactorial causal model of brain (dis)organization and therapeutic intervention: Application to Alzheimer’s disease , 2017, NeuroImage.
[29] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[30] P E Fraser,et al. A kinetic model for amyloid formation in the prion diseases: importance of seeding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] Michele Vendruscolo,et al. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer’s disease , 2016, Science Advances.
[32] F. Oosawa,et al. A theory of linear and helical aggregations of macromolecules. , 1962, Journal of molecular biology.
[33] M. C. Tesi,et al. A QUALITATIVE MODEL FOR AGGREGATION-FRAGMENTATION AND DIFFUSION OF β-AMYLOID IN ALZHEIMER’S DISEASE , 2014 .
[34] Michele Vendruscolo,et al. A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity , 2017, Proceedings of the National Academy of Sciences.
[35] Martin Beibel,et al. Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.
[36] V. Jansen,et al. Designing drugs to stop the formation of prion aggregates and other amyloids. , 2000, Biophysical chemistry.
[37] Lawrence M. Wein,et al. A mathematical model of the impact of novel treatments on the Aβ burden in the Alzheimer’s brain, CSF and plasma , 2015, Bulletin of mathematical biology.
[38] C. Dobson,et al. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. , 2017, Annual review of biochemistry.
[39] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[40] C. Iadecola,et al. The Pathobiology of Vascular Dementia , 2013, Neuron.
[41] Alexander K. Buell,et al. Spatial propagation of protein polymerization. , 2014, Physical review letters.
[42] Michele Vendruscolo,et al. Chemical kinetics for drug discovery to combat protein aggregation diseases. , 2014, Trends in pharmacological sciences.
[43] D. Selkoe,et al. Nasal administration of amyloid‐β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease , 2000, Annals of neurology.
[44] Raibatak Das,et al. Modeling Effect of a γ-Secretase Inhibitor on Amyloid-β Dynamics Reveals Significant Role of an Amyloid Clearance Mechanism , 2011, Bulletin of mathematical biology.
[45] Franziska Matthäus. THE SPREAD OF PRION DISEASES IN THE BRAIN — MODELS OF REACTION AND TRANSPORT ON NETWORKS , 2009 .
[46] M. Diamond,et al. Prion-like mechanisms in neurodegenerative diseases , 2010, Nature Reviews Neuroscience.
[47] Chengjie Xiong,et al. Age and amyloid effects on human central nervous system amyloid‐beta kinetics , 2015, Annals of neurology.
[48] Tuomas P. J. Knowles,et al. The Kinetics and Mechanisms of Amyloid Formation , 2013 .
[49] M. Eigen,et al. Prionics or the kinetic basis of prion diseases. , 1996, Biophysical chemistry.
[50] Michele Vendruscolo,et al. Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. , 2011, The Journal of chemical physics.
[51] P. Lansbury,et al. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.
[52] Nick C Fox,et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. , 2014, The New England journal of medicine.
[53] M. Weiner,et al. A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.
[54] Adam Douglass,et al. Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition , 2004, PLoS biology.
[55] R. Motter,et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.
[56] S. Prusiner. Novel proteinaceous infectious particles cause scrapie. , 1982, Science.
[57] P. Lantos,et al. The spatial patterns of prion protein deposits in Creutzfeldt–Jakob disease: comparison with β-amyloid deposits in Alzheimer's disease , 2001, Neuroscience Letters.
[58] David C. Krakauer,et al. The spatial dynamics of prion disease , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[59] Martin A. Nowak,et al. Prion infection dynamics , 1998 .
[60] Dennis W. Dickson,et al. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies , 2015, Acta Neuropathologica.
[61] George B. Benedek,et al. Kinetic theory of fibrillogenesis of amyloid β-protein , 1997 .
[62] Charles Duyckaerts,et al. Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies , 2015, Acta Neuropathologica.
[63] Michele Vendruscolo,et al. Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations. , 2011, The Journal of chemical physics.
[64] R. Murphy,et al. A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. , 2001, Biophysical journal.
[65] E. Siemers,et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. , 2014, The New England journal of medicine.
[66] Harry LeVine,et al. The cerebral proteopathies , 2000, Neurobiology of Aging.
[67] Michele Vendruscolo,et al. Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method , 2017, Science Advances.
[68] Thorsten Pöschel,et al. Kinetics of prion growth. , 2003, Biophysical journal.
[69] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[70] Regina M Murphy,et al. Peptide aggregation in neurodegenerative disease. , 2002, Annual review of biomedical engineering.
[71] Michele Vendruscolo,et al. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.
[72] Thierry Goudon,et al. Scaling limit of a discrete prion dynamics model , 2009, 0907.2297.
[73] Stephen J. DeArmond,et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.
[74] Leah Edelstein-Keshet,et al. Chemotactic signaling, microglia, and Alzheimer’s disease senile plaques: Is there a connection? , 2003, Bulletin of mathematical biology.
[75] S. Prusiner,et al. Molecular biology of prion diseases , 1991, Science.
[76] Michael Weiner,et al. Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease. , 2015, Cell reports.
[77] Ishwar K. Puri,et al. Mathematical Modeling for the Pathogenesis of Alzheimer's Disease , 2010, PloS one.
[78] J. Morris,et al. Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.
[79] TIKVAH ALPER,et al. Does the Agent of Scrapie Replicate without Nucleic Acid ? , 1967, Nature.
[80] Ronald Melki,et al. Prion-like transmission of protein aggregates in neurodegenerative diseases , 2010, Nature Reviews Molecular Cell Biology.
[81] Andrea Tosin,et al. Microscopic and macroscopic models for the onset and progression of Alzheimer's disease , 2017, 1703.10774.
[82] Michele Vendruscolo,et al. Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation , 2016, Nature Communications.
[83] Michele Vendruscolo,et al. Nucleated polymerization with secondary pathways. III. Equilibrium behavior and oligomer populations. , 2011, The Journal of chemical physics.
[84] Carole J. Proctor,et al. Investigating Interventions in Alzheimer's Disease with Computer Simulation Models , 2013, PloS one.
[85] Murray Grossman,et al. Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis , 2013, Annals of neurology.
[86] Thomas C T Michaels,et al. Dynamics of protein aggregation and oligomer formation governed by secondary nucleation. , 2015, The Journal of chemical physics.
[87] Christopher M. Dobson,et al. Protein-misfolding diseases: Getting out of shape , 2002, Nature.
[88] Laurent Pujo-Menjouet,et al. A mathematical analysis of the dynamics of prion proliferation. , 2006, Journal of theoretical biology.
[89] Mathias Jucker,et al. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases , 2013, Nature.
[90] Franziska Matthäus,et al. Diffusion versus network models as descriptions for the spread of prion diseases in the brain. , 2006, Journal of theoretical biology.
[91] Richard D. Leapman,et al. Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.
[92] Sara Linse,et al. Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides , 2014, Proceedings of the National Academy of Sciences.
[93] Yves Achdou,et al. A qualitative model for aggregation and diffusion of $$\beta $$-amyloid in Alzheimer’s disease , 2013, Journal of mathematical biology.
[94] Christoph Walker,et al. On the solvability of a mathematical model for prion proliferation , 2006 .
[95] Regina M. Murphy,et al. Probing the Kinetics of β-Amyloid Self-Association , 2000 .
[96] H. Braak,et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.
[97] D C Krakauer,et al. Mapping the parameters of prion-induced neuropathology. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[98] Tuomas P. J. Knowles,et al. An Analytical Solution to the Kinetics of Breakable Filament Assembly , 2009, Science.
[99] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[100] Michele Vendruscolo,et al. Hamiltonian Dynamics of Protein Filament Formation. , 2016, Physical review letters.
[101] R. Motter,et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease , 2000, Nature Medicine.
[102] M. Diamond,et al. Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.
[103] Tuomas P. J. Knowles,et al. Quantitative analysis of intrinsic and extrinsic factors in the aggregation mechanism of Alzheimer-associated Aβ-peptide , 2016, Scientific Reports.
[104] F. Brauer,et al. Mathematical Models in Population Biology and Epidemiology , 2001 .
[105] Alan C. Evans,et al. Epidemic Spreading Model to Characterize Misfolded Proteins Propagation in Aging and Associated Neurodegenerative Disorders , 2014, PLoS Comput. Biol..
[106] Suzanne S. Sindi,et al. A study in nucleated polymerization models of protein aggregation , 2015, Appl. Math. Lett..
[107] Michele Vendruscolo,et al. From macroscopic measurements to microscopic mechanisms of protein aggregation. , 2012, Journal of molecular biology.
[108] M A Nowak,et al. Quantifying the kinetic parameters of prion replication. , 1999, Biophysical chemistry.
[109] Tuomas P. J. Knowles,et al. Scaling and dimensionality in the chemical kinetics of protein filament formation , 2016 .
[110] Bruno Franchi,et al. From a Microscopic to a Macroscopic Model for Alzheimer Disease: Two-Scale Homogenization of the Smoluchowski Equation in Perforated Domains , 2016, J. Nonlinear Sci..
[111] Markus Tolnay,et al. The propagation of prion-like protein inclusions in neurodegenerative diseases , 2010, Trends in Neurosciences.
[112] Norbert Schuff,et al. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.
[113] Michele Vendruscolo,et al. The molecular chaperone Brichos breaks the catalytic cycle that generates toxic Aβ oligomers , 2015, Nature Structural &Molecular Biology.
[114] D. Kirschner,et al. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[115] E. J. Field,et al. The infective process in scrapie. , 1968, Lancet.
[116] Tuomas P. J. Knowles,et al. Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer’s disease , 2016, Proceedings of the National Academy of Sciences.
[117] Avner Friedman,et al. Mathematical model on Alzheimer’s disease , 2016, BMC Systems Biology.
[118] Michele Vendruscolo,et al. Molecular mechanisms of protein aggregation from global fitting of kinetic models , 2016, Nature Protocols.